Funding for this research was provided by:
National Key Research and Development Program of China (No. 2016YFC1302204, No. 2017YFC1308600)
National Natural Science Foundation of China (No. 81872071, No. 81672502, No. 31802142, No. 81902664)
Natural Science Foundation of Chongqing (No. cstc2019jcyj-zdxmX0033)
Fundamental Research Funds for Central Universities of the Central South University (No. XDJK2019C089)
Chongqing Graduate Student Research Innovation Project (No.CYB18105, No. CYS18124)
Fundamental Research Funds for the Central Universities (No. SWU120009)
Received: 28 June 2020
Accepted: 19 October 2020
First Online: 30 October 2020
Change Date: 18 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13046-022-02503-1
Ethics approval and consent to participate
: All animal experiments were conducted in accordance with the Guidelines for Animal Health and Use (Ministry of Science and Technology of China, 2006). The tumor mass of GAM-AD was from The Ninth People’s Hospital of Chongqing. With the consent of the patient’s family, we carried out the PDX model experiment. Besides, the patient’s privacy has been fully protected.
: The corresponding author and all the co-authors have agreed to the publication of the manuscript to Journal of Experimental and Clinical Cancer Research as a research article and declare that they have no conflict of interest as to the results presented.
: The authors declare no conflict of interest.